TOP
PHILOSOPHY
PHILOSOPHY
GOAL
PERSPECTIVES
CAPAVILITIES
TEAM
INVESTMENT
INVESTMENT
PORTFOLIO
UPDATE
CONTACT
JP
EN
JP
EN
UPDATE
NEWS
2021.01.15
MIJ invests in Blueberry Therapeutics Ltd.
2020.11.30
MIJ has invested in ILC Therapeutics
2020.08.03
Stock market listing of investee company Modalis Therapeutics Corporation
2020.02.14
MIJ invests in DiscGenics
2019.12.24
MIJ invests in Gene Therapy Research Institution Co., Ltd.
2019.03.19
MIJ invests in CellGenTech, Inc.
2019.03.19
MIJ invests in EdiGENE Corporation (now Modalis Therapeutics Corporation)
2018.09.19
MIJ enters into a capital agreement with SanBio Co, Ltd.
2018.05.15
Establishment of a consortium providing one-stop support for the processes following healthcare start-ups’ clinical development
more
NEWS RELEASE
2021.01.29
Blueberry Therapeutics announces extension of its Series B round with investment from Medical Incubator Japan and US Dermatology Syndicate
2020.12.01
UK biotech company ILC Therapeutics announces first international investment
2020.07.01
MIJ Launches a New Biotech Fund in Partnership with Nippon Shinyaku and Torii Pharmaceutical. Promoting the discovery and nurturing of innovative start-ups in the field of bioscience in Japan and overseas, focusing on the UK.
2018.09.10
Medical Incubator Japan K.K. (MIJ) to establish a capital and business agreement with SanBio Co, Ltd. MIJ will support acceleration of proper use/distribution of regenerative cell medicine SB623.
more
